Archive for the ‘Apricus Bio’ Category

Apricus Bio

January 9th, 2012 | Posted in 2012, Apricus Bio

Apricus Bio – San Diego:  And Stellar Pharmaceuticals inc, a Canadian public company, have signed an exclusive license agreement under which Steller Pharma has the exclusive right to sell Aprius Bio’s MycoVa product for the treatment of onychomycosis (nail fungus) in Canada (following receipt of Canadian regulatory approval for the product).  The exclusive license agreement […]